Inventor · disambiguated record
John S. Petersen
Also filed as: PETERSEN JOHN · PETERSEN JOHN S
52 granted patents·19 pending applications·1,413 citations·filing 1991–2025
99Inventor score
Top patents by PatentIndex Score
71 records- 0198US5173213ACorrosion and anti-foulant composition and method of useBAKER HUGHES INC·Filed 1991·Granted Dec 22, 1992·110 cites·5 claims
- 0297US10010544B2METAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2017·Granted Jul 3, 2018·11 cites·50 claims
- 0397US9730955B2Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2016·Granted Aug 15, 2017·10 cites·10 claims
- 0497US9585909B2Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2016·Granted Mar 7, 2017·10 cites·10 claims
- 0597US6733780B1Direct compression polymer tablet coreGENZYME CORP·Filed 2000·Granted May 11, 2004·122 cites·19 claims
- 0697US6541167B2Optical proximity correctionASML MASKTOOLS BV·Filed 2001·Granted Apr 1, 2003·75 cites·14 claims
- 0796US10159692B2Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2017·Granted Dec 25, 2018·8 cites·2 claims
- 0896US9329484B1Apparatus and method of direct writing with photons beyond the diffraction limit using two-color resistPERIODIC STRUCTURES INC·Filed 2015·Granted May 3, 2016·16 cites·9 claims
- 0996US9173956B2METAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2014·Granted Nov 3, 2015·22 cites·59 claims
- 1095US11304944B2MetAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2020·Granted Apr 19, 2022·3 cites·42 claims
- 1195US9757373B2MetAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2016·Granted Sep 12, 2017·13 cites·58 claims
- 1295US9750737B2METAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2016·Granted Sep 5, 2017·11 cites·51 claims
- 1395US9433600B2METAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2015·Granted Sep 6, 2016·15 cites·51 claims
- 1495US9320805B2Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereofPETERSEN JOHN S·Filed 2011·Granted Apr 26, 2016·15 cites·8 claims
- 1595US6335130B1System and method of providing optical proximity correction for features using phase-shifted halftone transparent/semi-transparent featuresASML MASKTOOLS BV·Filed 2000·Granted Jan 1, 2002·65 cites·10 claims
- 1695US6294163B1Polymers containing guanidinium groups as bile acid sequestrantsGELTEX PHARMA INC·Filed 1998·Granted Sep 25, 2001·87 cites·32 claims
- 1795US5929184AHydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrantsGELTEX PHARMA INC·Filed 1997·Granted Jul 27, 1999·96 cites·44 claims
- 1893US5374755ALiquid chromatography stationary phases with reduced silanol interactionsMILLIPORE CORP·Filed 1992·Granted Dec 20, 1994·133 cites·5 claims
- 1992US6248318B1Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymersGELTEX PHARMA INC·Filed 2000·Granted Jun 19, 2001·30 cites·12 claims
- 2091US6388736B1Imaging method using phase boundary masking with modified illuminationASM LITHOGRAPHY BV·Filed 2000·Granted May 14, 2002·39 cites·51 claims
- 2190US9969722B2Fumagillol derivatives and polymorphs thereofSYNDEVRX INC·Filed 2016·Granted May 15, 2018·7 cites·18 claims
- 2290US5900475AHydrophobic sequestrant for cholesterol depletionGELTEX PHARMA INC·Filed 1996·Granted May 4, 1999·56 cites·54 claims
- 2389US10588904B2METAP2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2018·Granted Mar 17, 2020·4 cites·47 claims
- 2488US9931358B2Direct compression polymer tablet coreGENZYME CORP·Filed 2017·Granted Apr 3, 2018·2 cites·18 claims
- 2588US9895449B2Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2016·Granted Feb 20, 2018·4 cites·35 claims
- 2688US6083497AMethod for treating hypercholesterolemia with unsubstituted polydiallylamine polymersGELTEX PHARMA INC·Filed 1997·Granted Jul 4, 2000·48 cites·12 claims
- 2788US5192405AProcess for effecting high efficiency separations by capillary electrophoresisMILLIPORE CORP·Filed 1991·Granted Mar 9, 1993·73 cites·16 claims
- 2888US2023165892A1Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2022·Application pending·0 cites
- 2987US10287277B2Fumagillol derivatives and polymorphs thereofSYNDEVRX INC·Filed 2018·Granted May 14, 2019·4 cites·11 claims
- 3086US9579343B2Direct compression polymer tablet coreGENZYME CORP·Filed 2014·Granted Feb 28, 2017·2 cites·20 claims
- 3186US6203785B1Poly(diallylamine)-based bile acid sequestrantsGELTEX PHARMA INC·Filed 1996·Granted Mar 20, 2001·54 cites·37 claims
- 3284US7638524B2Combination therapy for treating hypercholesterolemiaGENZYME CORP·Filed 2001·Granted Dec 29, 2009·12 cites·10 claims
- 3383USRE40084EOptical proximity correctionASML MASKTOOLS BV·Filed 2005·Granted Feb 19, 2008·6 cites·31 claims
- 3483US7125547B2Poly(diallylamine)-based bile acid sequestrantsGENZYME CORP·Filed 2003·Granted Oct 24, 2006·8 cites·18 claims
- 3582US8377428B2Low salt forms of polyallylamineGENZYME CORP·Filed 2009·Granted Feb 19, 2013·4 cites·10 claims
- 3682US8321008B2Combination cartridge and device for electrokinetic delivery of medicament to a treatment sitePETERSEN JOHN S·Filed 2006·Granted Nov 27, 2012·3 cites·19 claims
- 3782US5969090AHydrophobic sequestrant for cholesterol depletionGELTEX PHARMA INC·Filed 1998·Granted Oct 19, 1999·33 cites·12 claims
- 3882US2023048989A1Metap2 inhibitors and methods of treating obesitySYNDEVRX INC·Filed 2022·Application pending·0 cites
- 3981US8187631B2Direct compression polymer tablet coreTYLER JOSEPH·Filed 2009·Granted May 29, 2012·2 cites·20 claims
- 4080US6187762B1Polyvalent polymers for the treatment of rotavirus infectionGELTEX PHARMA INC·Filed 1999·Granted Feb 13, 2001·20 cites·21 claims
- 4180US5635333AAntireflective coating processSHIPLEY CO LLC·Filed 1994·Granted Jun 3, 1997·44 cites·22 claims
- 4277US10722532B2Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2018·Granted Jul 28, 2020·0 cites·11 claims
- 4377US2025288606A1Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2025·Application pending·0 cites
- 4475US6556361B1Projection imaging system with a non-circular aperture and a method thereofROCHESTER INST TECH·Filed 2000·Granted Apr 29, 2003·13 cites·24 claims
- 4574US6090250AChiral surfactants and methods for their use in chiral separationsWATERS INVESTMENTS LTD·Filed 1994·Granted Jul 18, 2000·48 cites·52 claims
- 4674US2021128607A1Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereofSYNDEVRX INC·Filed 2020·Application pending·0 cites
- 4773US9304410B2Apparatus and method of direct writing with photons beyond the diffraction limitMARKLE DAVID A·Filed 2013·Granted Apr 5, 2016·2 cites·20 claims
- 4873US8642232B2Method of direct writing with photons beyond the diffraction limitMARKLE DAVID A·Filed 2012·Granted Feb 4, 2014·2 cites·19 claims
- 4972US6264938B1Combination therapy for treating hypercholestrolemiaGELTEX PHARMA INC·Filed 1999·Granted Jul 24, 2001·18 cites·22 claims
- 5071US7541024B2Low salt forms of polyallylamineGENZYME CORP·Filed 2002·Granted Jun 2, 2009·4 cites·7 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John S. Petersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →